SAPPα AND/OR SAPPβ GLYCOSYLATION PATTERN AS A DIAGNOSTIC BIOMARKER OF ALZHEIMER'S DISEASE, AND METHOD AND KIT BASED ON SAME

摘要

The invention relates to: an in-vitro method for diagnosing Alzheimer's disease, wherein the glycosylation pattern of sAPPα and/or sAPPβ in a biological sample is determined; the sAPPα and/or sAPPβ biomarkers for use in the in-vitro method; and an Alzheimer's disease diagnosis kit, which comprises reagents for determining the sAPPα and/or sAPPβ glycosylation pattern in a biological sample.